Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report-Reference-Cited by-同舟云学术

Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report

Published:2021-05 Issue: Volume:13 Page:100212
ISSN:2666-3546
Container-title:Brain, Behavior, & Immunity - Health
language:en
Short-container-title:Brain, Behavior, & Immunity - Health

Author:

Bonaccorso Stefania,Ricciardi Angelo,Ouabbou Sophie^ORCID,Theleritis Christos^ORCID,Ross-Michaelides Arabella^ORCID,Metastasio Antonio^ORCID,Stewart Neil,Mohammed Marwa,Schifano Fabrizio

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland;Atkin;Br. J. Psychiatry,1996

2. Repurposing valproate to prevent acute respiratory distress syndrome/acute lung injury in COVID-19: a review of immunomodulatory action;Bhargava;Cancer Res. Stat. Treat.,2020

3. Clozapine in the time of COVID-19;Boland;Clin. Psychopharmacol. Neurosci.,2020

4. Clozapine prescribing in COVID-19 positive medical inpatients: a case series;Butler;Ther. Adv. Psychopharmacol.,2020

5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can lithium be used in the setting of clozapine commencement in patients with COVID‐19 associated neutropenia: A case report;Clinical Case Reports;2024-04

2. Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics;International Clinical Psychopharmacology;2024-01-22

3. Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated Study;Cureus;2023-12-13

4. Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial;Schizophrenia Research;2023-08

5. Clinical practice guideline for clozapine use in patients with COVID‐19;Progress in Neurology and Psychiatry;2023-01